Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCeiba Investme. Regulatory News (CBA)

Share Price Information for Ceiba Investme. (CBA)

Share Price is delayed by 15 minutes
Get Live Data
29.00    0.00 (0.00%)
Bid:
24.00
Ask:
34.00
Spread: 10.00 (41.667%)
Market Cap: £47.91m
CBA Live PriceLast checked at - London Stock Exchange

Intraday Ceiba Investme. Share Chart

Internalisation of Management

27 Apr 2023 07:00

RNS Number : 5535X
Ceiba Investments Limited
27 April 2023
 

 

 

CEIBA INVESTMENTS LIMITED

 

(TICKER: CBA, ISIN: GG00BFMDJH11)

Legal Entity Identifier: 213800XGY151JV5B1E88

 

Internalisation of Management

 

 

The Board of CEIBA Investments Limited ("CEIBA" or the "Company") is pleased to announce that Heads of Terms have been agreed with certain group companies of abrdn plc ("abrdn") for CEIBA to internalise the Company's investment management arrangements. 

 

Sebastiaan Berger, the lead fund manager of CEIBA and a current employee of abrdn, will move to CEIBA as Chief Executive Officer, together with the existing management team (collectively the "Management Team") to ensure continuity of service.

 

Concurrently, 4K Keys Limited ("4K Keys"), a company owned by the Management Team, that currently provides consulting services to abrdn in connection with the management of CEIBA, will be appointed to provide strategic consulting services in respect of the real estate assets of the Company's subsidiaries aimed at generating positive cash flow for such subsidiaries and cash distributions to CEIBA and its shareholders.

 

There will be no change to the Board of Directors of the Company as a result of the internalisation.

 

Following the completion of the internalisation process, CEIBA will become a self-managed alternative investment fund. Subject to contract, the internalisation is expected to become effective on 30 June 2023.

 

John Herring, Chairman of CEIBA, said "The Board has concluded that internalising the Company's investment management is in the best interests of shareholders as it will substantially reduce the operating costs of the Company. The retention of the current Management Team provides continuity of knowledge and experience alongside the non-executive Board. On behalf of the Board of CEIBA, I would like to thank the team at abrdn for their support over the last 5 years and look forward to the next stage in CEIBA's development."

 

Neil Slater, Global Head of Real Assets at abrdn commented, "abrdn has been involved with CEIBA as manager and shareholder since its London listing in 2018. We have a large and successful real estate team managing many mandates where our research and process can deliver greater value to clients. CEIBA invests in a specialist area of the market where our approach is less able to add value, so we believe it is in shareholders' best interest for CEIBA to focus on cost-savings and for the internalisation to occur. We fully support this and remain significant shareholders in the Company. We have had constructive discussions with the Board and Management Team of CEIBA to facilitate the internalisation and we wish them well."

 

Sebastiaan Berger, lead fund manager of CEIBA, stated, "While the geo-political backdrop for the Company over the last five years has been very challenging, the return of tourism to Cuba and the easing of U.S. sanctions means that the prospect of healthy future income streams (in particular once Cuba's economy and liquidity position improve) in combination with the substantial cost reduction that is being achieved by the internalisation of management is good news for the Company and its stakeholders. The Management Team of CEIBA is fully committed and aligned to work towards the Company's success."

 

Contacts:

Evan Bruce-Gardyne

abrdn plc

Tel : 0131 372 2200

 

James Maxwell/James Waterlow

Singer Capital Markets

Tel : 020 7496 3000

 

 

Important Information

This information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

--- ENDS -----

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAIFMMTMTTTBBJ
12
Date   Source Headline
5th Jun 20268:33 amRNSTrading Update
27th May 20263:39 pmRNSHolding(s) in Company
22nd May 20262:30 pmRNSHolding(s) in Company
20th May 20263:37 pmRNSHolding(s) in Company
19th May 20261:07 pmRNSHolding(s) in Company
15th May 202612:40 pmRNSDirector/PDMR Shareholding
12th May 20267:00 amRNSIssue of Equity
30th Apr 20267:00 amRNSAnnual Financial Report
14th Apr 20264:46 pmRNSResult of EGM
1st Apr 202611:21 amRNSFurther re Second Amendment of Bond Instrument
27th Feb 20265:14 pmRNSFurther re Second Amendment of Bond Instrument
27th Feb 20262:26 pmRNSDirectorate change
13th Feb 20265:13 pmRNSStatement re Second Amendment of Bond Instrument
13th Feb 20263:20 pmRNSDirector Declaration
12th Feb 20265:32 pmRNSChange of Auditor
5th Feb 20267:00 amRNSTrading Update - Consultation with Bondholders
26th Jan 20263:36 pmRNSDirector/PDMR Shareholding
23rd Dec 20251:39 pmRNSNet Asset Value(s)
4th Dec 20253:25 pmRNSAppointment of Senior Independent Director
2nd Oct 20252:48 pmRNSDirector/PDMR Shareholding
29th Sep 20257:00 amRNSHalf-year Report
12th Sep 20253:16 pmRNSDirectorate Change
8th Jul 20257:00 amRNSTrading Update - Payment to Bondholders
4th Jul 202512:49 pmRNSDirectorate Change
3rd Jul 20253:14 pmRNSResult of AGM
1st Jul 20251:35 pmRNSNet Asset Value(s)
30th Apr 20257:00 amRNSAnnual Financial Report
28th Apr 202510:26 amRNSDirectorate Change
3rd Feb 20257:00 amRNSStatement re Amendment of Bond Instrument
13th Jan 20255:51 pmRNSStatement re Amendment of Bond Instrument
11th Dec 20241:31 pmRNSNet Asset Value(s)
7th Oct 202410:55 amRNSDirector/PDMR Shareholding
7th Oct 20247:00 amRNSStatement re Update from the Chairman
27th Sep 20247:00 amRNSHalf-year Report to 30 June 2024
13th Aug 20248:36 amRNSDirectorate Change
20th Jun 20243:09 pmRNSDirector/PDMR Shareholding
20th Jun 20247:00 amRNSNet Asset Value(s)
18th Jun 20244:53 pmRNSResult of AGM
30th Apr 20247:00 amRNSAnnual Financial Report
25th Mar 202411:03 amRNSDirectorate Change
17th Jan 20247:00 amRNSInvestment Update
27th Dec 20239:17 amRNSNet Asset Value(s)
18th Dec 20238:54 amRNSDirector/PDMR Shareholding
3rd Nov 202310:36 amRNSHolding(s) in Company
1st Nov 20239:05 amRNSDirector/PDMR Shareholding
27th Oct 202311:11 amRNSDirector/PDMR Shareholding
16th Oct 20238:37 amRNSAppointment of Non-Executive Director
12th Oct 20234:26 pmRNSDirector/PDMR Shareholding
5th Oct 202310:24 amRNSDirector/PDMR Shareholding
29th Sep 20237:00 amRNSHalf-year Report
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.